Company / Profit Margin
Bristol Myers Squibb Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
14.6%
FY2025
5-year range
-21.2% / 15.1%
FY2021-FY2025
Trend
+179.0%
vs FY2024
Sector context
#33 of 146
Health Care
What the data says
Bristol Myers Squibb's profit margin of 14.6% is higher than 77% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from -21.2% in FY2022 to 22.9% in FY2018.
Based on SEC 10-K filings.
14.6% in FY2025 with a 5-year CAGR of +35.8%. Top quartile in the Health Care sector.
Declined from 15.1% to 14.6% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +35.8pp
- 5-Year Change
- +35.8pp
- 10-Year Change
- -
Sector benchmark
Top 23% in Health CareTop 23% of 146This company 14.6% Sector average -796.3%
▼
+101.8% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 179.0% year-over-year.
- Currently 810.9pp above the Health Care sector average.
- Peak profit margin was recorded in FY2018.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.6% | +179.0% |
| FY2024 | -18.5% | -222.9% |
| FY2023 | 15.1% | +171.1% |
| FY2022 | -21.2% | -261.2% |
| FY2021 | 13.2% | +162.0% |
| FY2020 | -21.2% | -537.1% |
| FY2019 | 4.9% | -78.9% |
| FY2018 | 22.9% | +373.0% |
| FY2017 | 4.9% | -61.6% |
| FY2016 | 12.6% | -19.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026